Yu LL - Search Results

1

CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity.

Yu LL, Xiao Q, Yu B, Lv QL, Liu ZQ, Yin JY. Yu LL, et al. Among authors: yu b. Cancer Lett. 2023 Jun 28;564:216219. doi: 10.1016/j.canlet.2023.216219. Epub 2023 May 3. Cancer Lett. 2023. PMID: 37146937 Free article. Review.

2

A two-stage genome-wide association study identifies novel germline genetic variations in CACNA2D3 associated with radiotherapy response in nasopharyngeal carcinoma.

Yu LL, Hu BW, Huang HX, Yu B, Xiao Q, Lv QL, Luo CH, Guo CX, Li JG, Xie XX, Yin JY. Yu LL, et al. Among authors: yu b. J Transl Med. 2023 Jan 9;21(1):11. doi: 10.1186/s12967-022-03819-4. J Transl Med. 2023. PMID: 36624463 Free PMC article.

3

Establishing a Prediction Model for the Efficacy of Platinum-Based Chemotherapy in NSCLC Based on a Two Cohorts GWAS Study.

Xiao Q, Mao C, Gao Y, Huang H, Yu B, Yu L, Li X, Mao X, Zhang W, Yin J, Liu Z. Xiao Q, et al. J Clin Med. 2023 Feb 7;12(4):1318. doi: 10.3390/jcm12041318. J Clin Med. 2023. PMID: 36835855 Free PMC article.

4

The MSH2 c.793-1G>A variant disrupts normal splicing and is associated with Lynch syndrome.

Li Y, Yu L, Cui J, Yin J, Wu W. Li Y, et al. Front Oncol. 2023 Jul 19;13:1131011. doi: 10.3389/fonc.2023.1131011. eCollection 2023. Front Oncol. 2023. PMID: 37538120 Free PMC article.

5

Identification of SARS-CoV-2 m6A modification sites correlate with viral pathogenicity.

Liu K, Zhang YZ, Yin H, Yu LL, Cui JJ, Yin JY, Luo CH, Guo CX. Liu K, et al. Among authors: yu ll. Microbes Infect. 2024 Jan-Feb;26(1-2):105228. doi: 10.1016/j.micinf.2023.105228. Epub 2023 Sep 20. Microbes Infect. 2024. PMID: 37734532 Free article.

6

SOX30 Overexpression Reflects Tumor Invasive Degree, Lymph Node Metastasis and Predicts Better Survival in Colorectal Cancer Patients: A Long-Term Follow-Up Cohort Study.

Li C, Li P, Yu L, Sun Q, Gu B, Sun Y, Sun L. Li C, et al. Front Surg. 2022 Jun 28;9:898952. doi: 10.3389/fsurg.2022.898952. eCollection 2022. Front Surg. 2022. PMID: 35836594 Free PMC article.

7

Uric acid-lowering effect of harpagoside and its protective effect against hyperuricemia-induced renal injury in mice.

Fu Q, Zhang JJ, Zhu QF, Yu LL, Wang F, Li J, He X, Ao JL, Xu GB, Wei MC, Liao XJ, Liao SG. Fu Q, et al. Among authors: yu ll. Biochem Biophys Res Commun. 2024 Apr 30;716:150038. doi: 10.1016/j.bbrc.2024.150038. Online ahead of print. Biochem Biophys Res Commun. 2024. PMID: 38704891

8

Tunable Macroscopic Alignment of Self-Assembling Peptide Nanofibers.

Farsheed AC, Zevallos-Delgado C, Yu LT, Saeidifard S, Swain JWR, Makhoul JT, Thomas AJ, Cole CC, Garcia Huitron E, Grande-Allen KJ, Singh M, Larin KV, Hartgerink JD. Farsheed AC, et al. ACS Nano. 2024 May 3. doi: 10.1021/acsnano.4c02030. Online ahead of print. ACS Nano. 2024. PMID: 38699877

9

Targeted remodeling of the human gut microbiome using Juemingzi (Senna seed extracts).

Narrowe AB, Lemons JMS, Mahalak KK, Firrman J, den Abbeele PV, Baudot A, Deyaert S, Li Y, Yu LL, Liu L. Narrowe AB, et al. Among authors: yu ll. Front Cell Infect Microbiol. 2024 Apr 4;14:1296619. doi: 10.3389/fcimb.2024.1296619. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38638830 Free PMC article.

10

The Molecular Profile of Soil Microbial Communities Inhabiting a Cambrian Host Rock.

Huang T, Carrizo D, Sánchez-García L, Hu Q, Anglés A, Gómez-Ortiz D, Yu LL, Fernández-Remolar DC. Huang T, et al. Among authors: yu ll. Microorganisms. 2024 Mar 2;12(3):513. doi: 10.3390/microorganisms12030513. Microorganisms. 2024. PMID: 38543564 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

522 results

Search Page